313 related articles for article (PubMed ID: 16437659)
1. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.
Palestro G; Pellicano R; Fronda GR; Valente G; De Giuli M; Soldati T; Pugliese A; Taraglio S; Garino M; Campra D; Cutufia MA; Margaria E; Spinzi G; Ferrara A; Marenco G; Rizzetto M; Ponzetto A
World J Gastroenterol; 2005 Dec; 11(45):7131-5. PubMed ID: 16437659
[TBL] [Abstract][Full Text] [Related]
2. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
3. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
4. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.
Martín-de-Argila C; Boixeda D; Redondo C; Alvarez I; Gisbert JP; García Plaza A; Cantón R
Scand J Gastroenterol; 1997 Apr; 32(4):303-7. PubMed ID: 9140150
[TBL] [Abstract][Full Text] [Related]
5. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
[TBL] [Abstract][Full Text] [Related]
6. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
7. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
9. IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.
de la Cruz-Herrera CF; Flores-Luna L; Gutierrez-Xicotencatl L; Chihu-Amparan L; Sánchez-Aleman MA; Lazcano-Ponce E; Torres J; Ayala G
J Med Microbiol; 2013 Apr; 62(Pt 4):591-598. PubMed ID: 23288428
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology.
Komoto K; Haruma K; Kamada T; Tanaka S; Yoshihara M; Sumii K; Kajiyama G; Talley NJ
Am J Gastroenterol; 1998 Aug; 93(8):1271-6. PubMed ID: 9707050
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma.
Chua TS; Fock KM; Chan YH; Dhamodaran S; Sim CS; Ng TM; Teo EK
Helicobacter; 2002 Aug; 7(4):257-64. PubMed ID: 12165034
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
[TBL] [Abstract][Full Text] [Related]
13. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer.
Karami N; Talebkhan Y; Saberi S; Esmaeili M; Oghalaie A; Abdirad A; Mostafavi E; Hosseini ME; Mohagheghi MA; Mohammadi M
Asian Pac J Cancer Prev; 2013; 14(3):1813-7. PubMed ID: 23679279
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions.
Con SA; Valerín AL; Takeuchi H; Con-Wong R; Con-Chin VG; Con-Chin GR; Yagi-Chaves SN; Mena F; Brenes Pino F; Echandi G; Kobayashi M; Monge-Izaguirre M; Nishioka M; Morimoto N; Sugiura T; Araki K
J Gastroenterol; 2006 Jul; 41(7):632-7. PubMed ID: 16932999
[TBL] [Abstract][Full Text] [Related]
16. Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?
Pellicano R; Parravicini PP; Bigi R; Gandolfo N; Aruta E; Gai V; Figura N; Angelino P; Rizzetto M; Ponzetto A
New Microbiol; 2002 Jul; 25(3):315-21. PubMed ID: 12173773
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
18. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
19. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
[TBL] [Abstract][Full Text] [Related]
20. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
